Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Rush University Medical Center
This project will enroll patients with non-diffuse liver disease who are candidates for chemo or radioembolization to treat or manage the disease during an image guided intervention. Subjects will undergo a CT perfusion study of the liver prior to the radioembolizaiton mapping procedure or prior to the chemoembolization treatment. During the radioembolization mapping or chemoembolization procedure, 2 DynaCT acquisitions on the interventional C-arm will be acquired (the second during an injection of an iodinated contrast material) and will be processed using Siemens' PBV software to generate blood volume maps. The diagnostic accuracy of the two approaches to assess the vascularity of the tumors will be assessed.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
HCC or metastatic liver disease
Candidate for radioembolization or chemoembolization
You may not be if
Pregnant
Iodine allergy
Clareo Health | Blood Volume Assessment of Hepatocellular and Metastatic Carcinomas in the Liver